Axert (Almotriptan Malate) - Current Clinical Trials

Axert Related Clinical Trials

The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain [Completed]

A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache [Completed]

A Study of 3 Dosage Strengths of Aalmotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents [Completed]

Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine [Completed]

Standardized sTudy With Almotriptan in eaRly Treatment of Migraine [Recruiting]

A 1-Year Study in Adolescents to Assess the Long-Term Safety of Almotriptan Malate When Treating Their Migraine Headaches [Completed]

Detoxification and Treatment of Subjects With Medication Overuse Headache [Recruiting]

Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers [Completed]